Gonadotropin-releasing hormone receptor inhibits triple-negative breast cancer proliferation and metastasis

BACKGROUND: Gonadotropin-releasing hormone receptor (GnRHR) is expressed in several malignant tumors and inhibits the proliferation and metastasis of cancer cells, but its role in triple-negative breast cancers (TNBCs) is unclear. This study investigated the biological effects of GnRHR and their inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cai-Ping, Lu, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Pre-Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918972/
https://www.ncbi.nlm.nih.gov/pubmed/35264044
http://dx.doi.org/10.1177/03000605221082895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918972/
https://www.ncbi.nlm.nih.gov/pubmed/35264044
http://dx.doi.org/10.1177/03000605221082895

Ejemplares similares